''Young children and old age persons with comorbidities are the...
Category:
Health
Latest
Brain stroke is the second most common cause of death in India:top health expert
Delivering a keynote address at the event titled, "Stroke care and...
Over 10 million older adults in India likely have dementia: AI study
''Our research was based on the first and only nationally...
Insurers drop appeal against UK COVID-19 payout ruling on three policies
appeals linked to the Resilience, Eaton Gate Retail, and Eaton Gate Pubs & Restaurants policies have now been dropped, legal documents show, raising hopes that hundreds of vulnerable businesses could see their claims processed without further delay.
A spokesman for RSA, one of the largest of the six insurers, said it would work with broker Marsh to make interim payments where appropriate.
Businesses across the world have been locked in disputes with insurance companies over pandemic-related payouts.
COVID-19: India records 55,839 new infections, 702 deaths
The active cases of coronavirus infection remained below eight lakh for the sixth consecutive day
There are 7,15,812 active cases of coronavirus infection in the country which accounts for 9.29 per cent of the total caseload, the data stated
According to the Indian Council of Medical Research (ICMR), a cumulative total of 9,86,70,363 samples have been tested up to October 21, of which 14,69,984 were tested on Wednesday.
Number of South Koreans dying after flu shot rises, prompts vaccine worries
South Korea’s vaccines come from a variety of sources. Manufacturers include local drug makers GC Pharma, SK Bioscience and Ilyang Pharmaceutical Co, along with France’s Sanofi and Britain’s Glaxosmithkline. Distributors include LG Chem Ltd and Boryung Biopharma Co. Ltd., a unit of Boryung Pharm Co. Ltd..GC Pharma, LG Chem, SK Bioscience and Boryung declined to comment. Ilyang Pharmaceutical, Sanofi and GSK could not immediately be reached for comment.
Digital health ID not mandatory for accessing COVID vaccine: Health Ministry
The Health Secretary”s remarks came a day after Prime Minister Narendra Modi said India is working on putting a robust vaccine delivery system in place and its digitized network, along with the new digital health ID, will be used to ensure its success. The PM was speaking at the Grand Challenges Annual Meeting on Monday.
“The NDHM, as it exists today, does not make a digital ID or health ID mandatory to receive service under the digital ecosystem that NDHM is creating. To say it would become mandatory for vaccination and those who do not have health ID”s would be deprived is probably not the right interpretation,” Union Health Secretary Rajesh Bhushan said at a press conference.
Insurance claims related to COVID-19 treatment rise in Septembe
Based on its analysis of industry data, insurance aggregator Policybazaar.com said “most people filing the claim for COVID-19 treatment are senior citizens of age group 60 years and more, followed by people in the age bracket of 41-45 years”.
In September, the insurance aggregator said COVID-19-related claims accounted for 40 per cent of the total health insurance claims. It has been steadily increasing from 8 per cent in May. In July and August, it stood at 23 per cent and 34 per cent, respectively.
COVID-19 cases in India climb to 76,51, 107
The active cases of coronavirus infection remained below 8 lakh for the fifth consecutive day.
There are 7,40,090 active cases of coronavirus infection in the country which comprises 9.67 per cent of the total caseload, the data stated.
Pandemic speeds labour shift from humans to robots, WEF survey finds
“COVID-19 has accelerated the arrival of the future of work,” WEF Managing Director Saadia Zahidi said.
Further rate hardening expected,cyber insurance market to surpass $ 7bn in 2020:Munich Re
Recent experiences following the lockdown of public life and the business world in many countries have been a wake-up call regarding the staggering potential for systemic risks to result in losses that subsequently trigger many different repercussions. Yet it is by definition impossible to insure risks that lead to losses everywhere at the same time, thus violating the fundamental criterion of insurability, said Munich Re.
Interest rates have dropped to record lows once again in 2020. Against the backdrop of the coronavirus crisis, it is increasingly likely that the current interest-rate environment will continue to affect low-risk investments for the foreseeable future. These circumstances mean that sustained profits, in long-tail business and elsewhere, will only be possible if prices match the assumed risks, explained Munich Re..
AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority says
The regulator said testing of the vaccine would continue after the volunteer’s death. It provided no further details, citing medical confidentiality of those involved in trials.
The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian but did not say where the person lived.
IMF cuts Asia’s growth forecast, warns of pandemic-driven risks
India’s economy is likely to shrink 10.3% this year in stark contrast to China, which is set to expand 1.9%, the IMF said.
Asia’s economy is likely to grow 6.9% in 2021 thanks to the boost from expected stronger recoveries in China, the United States and the euro area, it said.
But the IMF said there were “considerable” risks such as the chance of a second wave of infections, escalating U.S. tensions and a potential return to tighter financial conditions.